“crispr” Archives

in
Entry Author Date Location
Scribe Therapeutics Sets Out to Write CRISPR Gene Editing’s Next Chapter 10/06/20 San Francisco
Lumen Bioscience Lands $16M to Engineer “Edible” Antibody Drugs 09/02/20 Seattle
Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More 08/14/20 National
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact 08/07/20 Boston
Verve Therapeutics Adds $63M to Edit Heart Attack Risk Out of Genes 06/11/20 Boston
Regeneron Pays Intellia $100M to Add Hemophilia to CRISPR R&D Pact 06/01/20 New York
After Inking Bristol Myers Pact, Repare Therapeutics Sets Sights on IPO 05/29/20 Boston
Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments 05/26/20 San Diego
Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More 05/08/20 National
Tango Adds $60M in CRISPR Hunt for Synthetically Lethal Cancer Drugs 04/09/20 Boston
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More 03/06/20 National
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019 02/12/20 National
FDA Clinical Hold Stops LogicBio’s Gene Editing Study Before It Starts 02/10/20 Boston
Beam Therapeutics IPO Raises $180M After Nearly Doubling Shares Offered 02/06/20 Boston
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More 01/31/20 National
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14 01/30/20 San Francisco
Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits 01/22/20 New York
Bio Roundup: EQRx’s Ambitions, Nektar No Vote, New Frazier Fund & More 01/17/20 National
Emendo Biotherapeutics Nabs $61M for “Next-Generation CRISPR” R&D 01/15/20 New York
A Safer CRISPR? Cyrus, Broad Institute Look to Quell Concerns 12/03/19 National
Bio Roundup: So Long Celgene, RNAi’s Arrival, Pharma in 2020 & More 11/22/19 National
Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More 11/08/19 National
eGenesis Lands $100M to Advance CRISPR-ed Pig Kidney to Human Test 11/07/19 Boston
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More 10/18/19 National
Beam Therapeutics Preps IPO and Sheds Light on Its Gene-Editing Drugs 09/27/19 Boston
Bio Roundup: Pelosi’s Reveal, Alder’s Deal, Biogen’s Fails & More 09/20/19 National
Phil Sharp, CRISPR’ing the Heart & the Duchenne Data Gap on Oct. 17 09/11/19 Boston
Challenging CRISPR, Trucode Raises $34M for New Gene-Editing System 09/10/19 San Francisco
Inari Reaps $89M and Eyes Global Farm Markets for Gene-Edited Seeds 08/06/19 Boston
GlycoMimetics Sickle Cell Drug Flops as Others Creep Forward 08/05/19 New York
Page 1 of 4 next page »